N-[2-Amino-4-(trifluoromethyl)phenyl]methanesulfonamide, 95.0%, 1g

4-Fluorophenylsulfonylethanol, 98.0%, 5g

Boron AAS standard solution, ROTI®Star, 500 ml, HDPE

(2E)-1-(2,5-dichlorophenyl)-3-(3-methylphenyl)prop-2-en-1-one, 95.0%, 10g

2-chloro-3-methylisonicotinaldehyde, 95.0%, 250mg

5-(4-Hydroxypiperidin-1-yl)thiophene-2-carbaldehyde, 95.0%, 5g

(2,6-Bis(benzyloxy)pyridin-3-yl)boronic acid, 98%, 25g

4-((4'-methoxy-[1,1'-biphenyl])-4-sulfonamido)benzoic acid, 95.0%, 250mg

(5-Chloro-1,3-dimethyl-1h-pyrazol-4-yl)methanol, 95%, 1g

Gilteritinib, 95%, 1g

5-(3,4-difluorophenyl)-4,5-dihydroisoxazole-3-carboxylic acid, 1g

(5-Phenyl-[1,3,4]oxadiazol-2-ylsulfanyl)-acetic acid, 250mg

(R)-tert-Butyl 2-amino-3-cyclohexylpropanoate, 95%, 1g